Protein family linked to autism suppresses the development of inhibitory synapses

A JCB study reveals that a neuronal protein linked to neurodevelopmental disorders suppresses the development of inhibitory synapses. MDGA1 disrupts the interaction between neuroligin-2 and neurexin-1, two synaptic cell adhesion molecules associated with autism and schizophrenia that promote inhibitory synapse development. In this co-culture assay, a neuron forms multiple presynapses (red) with a COS7 cell (right) expressing neuroligin-2 (blue) but only a few presynapses with a cell (left) coexpressing neuroligin-2 and MDGA1 (green). Credit: Pettem, K.L., et al. 2013. J. Cell Biol. doi:10.1083/jcb.201206028

Synapse development is promoted by a variety of cell adhesion molecules that connect neurons and organize synaptic proteins. Many of these adhesion molecules are linked to neurodevelopmental disorders; mutations in neuroligin and neurexin proteins, for example, are associated with autism and schizophrenia. According to a study in The Journal of Cell Biology, another family of proteins linked to these disorders regulates the function of neuroligins and neurexins in order to suppress the development of inhibitory synapses.

Like neurexins and neuroligins, the neuronal proteins MDGA1 and MDGA2 have been linked to autism and schizophrenia, but their function in neurodevelopment was unknown. Both MDGA proteins localize to the , and their extracellular domains are similar to those of cell adhesion molecules. On the other hand, postsynaptic neuroligin proteins are known to help synapses form by associating with neurexins on presynaptic membranes. Neuroligin-2 specifically boosts the development of , whereas neuroligin-1 promotes the development of excitatory synapses.

Ann Marie Craig and colleagues from the University of British Columbia investigated the function of MDGAs using co-culture assays, in which postsynaptic proteins like neuroligin-1 or -2 are expressed in non- and then tested for their ability to induce presynaptic differentiation in neighboring . MDGA1 didn't promote synapse formation in these assays. Instead, it inhibited the ability of neuroligin-2 to promote synapse development. The researchers found that MDGA1's extracellular domains bound to neuroligin-2, blocking its association with . The same domains were sufficient to inhibit neuroligin-2's synapse-promoting activity. In contrast, MDGA1 didn't show high affinity binding to, or inhibit the function of, neuroligin-1. This suggested that, by inhibiting neuroligin-2, MDGA1 might specifically suppress the development of inhibitory synapses, so Craig and colleagues investigated MDGA1 function in cultured hippocampal neurons.

"Overexpressing MDGA1 in neurons reduced the density of inhibitory synapses without affecting excitatory synapses," Craig says. Knocking down MDGA1, on the other hand, increased inhibitory synapse development but had no effect on .

"I can't think of any other proteins that specifically suppress inhibitory synapse formation," says Craig. Indeed, very few proteins in general have been identified as negative regulators of synapse development, compared to the many proteins that are known to promote synaptogenesis. The results suggest that function-altering mutations in the MDGA proteins may disrupt the balance of excitatory and inhibitory synapses in the brain, potentially explaining the development of autism and other neurodevelopmental disorders.

"This puts MDGAs in the same pathway as neurexins and neuroligins and strengthens the evidence for the involvement of synaptic organizing proteins in autism and schizophrenia," Craig explains. As well as investigating the function of MDGA2, the researchers want to explore the therapeutic potential of MDGA1 inhibitors, not only against autism and but also for the treatment of epilepsy, in which excitatory and inhibitory synapses are also imbalanced

More information: Pettem, K.L., et al. 2013. J. Cell Biol. doi:10.1083/jcb.201206028

Related Stories

Balancing connections for proper brain function

Jun 22, 2012

Neuropsychiatric conditions such as autism, schizophrenia and epilepsy involve an imbalance between two types of synapses in the brain: excitatory synapses that release the neurotransmitter glutamate, and ...

Researchers visualize formation of a new synapse

Jun 18, 2009

A protein called neuroligin that is implicated in some forms of autism is critical to the construction of a working synapse, locking neurons together like "molecular Velcro," a study lead by a team of UC Davis researchers ...

Capturing the birth of a synapse

May 27, 2009

Researchers have identified the locking mechanism that allows some neurons to form synapses to pass along essential information. Mutations of genes that produce a critical cell-adhesion molecule involved in ...

Recommended for you

Immune response may cause harm in brain injuries, disorders

41 minutes ago

Could the body's own immune system play a role in memory impairment and cognitive dysfunction associated with conditions like chronic epilepsy, Alzheimer's dementia and concussions? Cleveland Clinic researchers believe so, ...

One route to malaria drug resistance found

4 hours ago

Researchers have uncovered a way the malaria parasite becomes resistant to an investigational drug. The discovery, at Washington University School of Medicine in St. Louis, also is relevant for other infectious ...

Protein therapy successful in treating injured lung cells

4 hours ago

Cardiovascular researchers at The Ohio State University Wexner Medical Center have successfully used a protein known as MG53 to treat acute and chronic lung cell injury. Additionally, application of this protein proved to ...

User comments